BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31517370)

  • 1. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
    Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
    Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of natural product biosynthesis in actinobacteria.
    Bilyk O; Luzhetskyy A
    Curr Opin Biotechnol; 2016 Dec; 42():98-107. PubMed ID: 27058643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of secondary metabolism in actinomycetes.
    Abdelmohsen UR; Grkovic T; Balasubramanian S; Kamel MS; Quinn RJ; Hentschel U
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):798-811. PubMed ID: 26087412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter engineering of natural product biosynthetic gene clusters in actinomycetes: concepts and applications.
    Ji CH; Je HW; Kim H; Kang HS
    Nat Prod Rep; 2024 Apr; 41(4):672-699. PubMed ID: 38259139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and enhancement of caerulomycin A biosynthesis in marine-derived Actinoalloteichus sp. AHMU CJ021 by combinatorial genome mining strategies.
    Xie Y; Chen J; Wang B; Chen T; Chen J; Zhang Y; Liu X; Chen Q
    Microb Cell Fact; 2020 Aug; 19(1):159. PubMed ID: 32762690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.
    Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):343-70. PubMed ID: 26364200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in actinomycete research: an ActinoBase review of 2019.
    Prudence SMM; Addington E; Castaño-Espriu L; Mark DR; Pintor-Escobar L; Russell AH; McLean TC
    Microbiology (Reading); 2020 Aug; 166(8):683-694. PubMed ID: 32558638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural product discovery in soil actinomycetes: unlocking their potential within an ecological context.
    Schniete JK; Fernández-Martínez LT
    Curr Opin Microbiol; 2024 Jun; 79():102487. PubMed ID: 38733791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic biology and metabolic engineering of actinomycetes for natural product discovery.
    Palazzotto E; Tong Y; Lee SY; Weber T
    Biotechnol Adv; 2019 Nov; 37(6):107366. PubMed ID: 30853630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
    Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducing Global Expression of Actinobacterial Biosynthetic Gene Clusters.
    Pepler MA; Zhang X; Hindra ; Elliot MA
    Methods Mol Biol; 2022; 2489():157-171. PubMed ID: 35524050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial chromosomes to explore and to exploit biosynthetic capabilities of actinomycetes.
    Alduina R; Gallo G
    J Biomed Biotechnol; 2012; 2012():462049. PubMed ID: 22919271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. aMSGE: advanced multiplex site-specific genome engineering with orthogonal modular recombinases in actinomycetes.
    Li L; Wei K; Liu X; Wu Y; Zheng G; Chen S; Jiang W; Lu Y
    Metab Eng; 2019 Mar; 52():153-167. PubMed ID: 30529239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome mining for ribosomally synthesised and post-translationally modified peptides (RiPPs) reveals undiscovered bioactive potentials of actinobacteria.
    Poorinmohammad N; Bagheban-Shemirani R; Hamedi J
    Antonie Van Leeuwenhoek; 2019 Oct; 112(10):1477-1499. PubMed ID: 31123844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Molecular Tools for Genetic Engineering of Actinomycetes-The Source of Important Antibiotics and Other Valuable Compounds.
    Mitousis L; Thoma Y; Musiol-Kroll EM
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32784409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Scale Metabolic Reconstruction of Actinomycetes for Antibiotics Production.
    Mohite OS; Weber T; Kim HU; Lee SY
    Biotechnol J; 2019 Jan; 14(1):e1800377. PubMed ID: 30117679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Genomic Survey of the Natural Product Biosynthetic Potential of Actinomycetes Isolated from New Zealand Lichens.
    Hou P; Nowak VV; Taylor CJ; Calcott MJ; Knight A; Owen JG
    mSystems; 2023 Apr; 8(2):e0103022. PubMed ID: 36749048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical ecology of antibiotic production by actinomycetes.
    van der Meij A; Worsley SF; Hutchings MI; van Wezel GP
    FEMS Microbiol Rev; 2017 May; 41(3):392-416. PubMed ID: 28521336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development and application of ribosomal engineering in actinomycetes].
    Xie Y; Yao S; Li W; Shan R; Wu G; Tong T; Chen Q
    Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):546-564. PubMed ID: 35234381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.